Mitoxantrone hydrochloride and Caspofungin acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mitoxantrone hydrochloride (mitoxantrone hydrochloride) and Caspofungin acetate (caspofungin acetate). Common drug interactions include drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Mitoxantrone hydrochloride and Caspofungin acetate. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Mitoxantrone hydrochloride?

Mitoxantrone hydrochloride has active ingredients of mitoxantrone hydrochloride. eHealthMe is studying from 1,060 Mitoxantrone hydrochloride users. Check the latest studies of Mitoxantrone hydrochloride.

What is Caspofungin acetate?

Caspofungin acetate has active ingredients of caspofungin acetate. eHealthMe is studying from 1,724 Caspofungin acetate users. Check the latest studies of Caspofungin acetate.

On Aug, 07, 2026

23 people who take Mitoxantrone hydrochloride and Caspofungin acetate together, and have interactions are studied.

Mitoxantrone hydrochloride and Caspofungin acetate drug interactions.

What are the common drug interactions of Mitoxantrone Hydrochloride and Caspofungin Acetate, by gender? *:

female:

n/a

male:

Drug ineffective
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Osteonecrosis (death of bone)
Osteoporosis (bones weak and more likely to break)
Anaemia (lack of blood)
C-reactive protein increased
Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
Febrile neutropenia (fever with reduced white blood cells)
General physical health deterioration (weak health status)
Haematemesis (vomiting of blood)

What are the common drug interactions of Mitoxantrone Hydrochloride and Caspofungin Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Heart transplant
Pulmonary hypertension (increase in blood pressure in the lung artery)
Restrictive cardiomyopathy (a condition in which the walls of the lower chambers of the heart (the ventricles) are abnormally rigid and lack the flexibility)

10-19:

Back pain
Osteonecrosis (death of bone)
Osteoporosis (bones weak and more likely to break)
Anaemia (lack of blood)
Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
General physical health deterioration (weak health status)
Haematemesis (vomiting of blood)
Haematoma (collection of blood outside the blood vessels)
Oesophageal haemorrhage (bleeding from oesophagus)
Thrombocytopenia (decrease of platelets in blood)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Cerebral aspergillosis (pus collection with swelling in brain)
Drug ineffective
Drug resistance (reduction in effectiveness of a drug)
Fungal endocarditis (fungal infection of the inner layer of the heart)
Pathogen resistance

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 17 people, 73.91%
Bone Marrow Conditioning Regimen: 16 people, 69.57%
T-Cell Type Acute Leukaemia (a form of cancer of the white blood cells): 3 people, 13.04%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Mitoxantrone hydrochloride and Caspofungin acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously